About Penta
Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Brighter Future Award
Archivio
Voluntary Consent to Research on HIV-infected Children in the CHAPAS-4 and ODYSSEY HIV Clinical Trials
Detection of Potential Arbovirus Infections and Pregnancy Complications in Pregnant Women in Jamaica Using a Smartphone App (ZIKApp): Pilot Evaluation Study
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies
Penta endorses the International workshop on HIV and adolescence
PentaTr@ining holds first-ever jointly hosted course in Africa
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Controlling SARS-CoV-2 in schools using repetitive testing strategies
Double dose of dolutegravir to treat HIV in children also being treated for tuberculosis
2nd VERDI General Assembly highlights importance of synergies across cohorts and consortia
Combining Factorial and MAMS designs